Comments
Loading...

Journey Medical

DERMNASDAQ
Logo brought to you by Benzinga Data
$5.20
-0.03-0.57%
At close: -
$5.23
0.030.58%
After Hours: Nov 20, 4:17 PM EDT

Journey Medical (NASDAQ:DERM) Stock Quotes, Forecast and News Summary

Journey Medical Stock (NASDAQ: DERM) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jun
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$5.26
Close$5.20
Volume / Avg.71.98K / 87.86K
Day Range$5.05 - $5.38
52 Wk Range2.85 - 8.11
Market Cap$109.25M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest
1.35%
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
DERM
AVIR

FAQ

Q

How do I buy Journey Medical (DERM) stock?

A

You can purchase shares of Journey Medical (NASDAQ:DERM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Journey Medical (DERM) competitors?

Q

What is the forecast, or price target, for Journey Medical (DERM) stock?

A

Journey Medical has a consensus price target of $9.64.

Q

What is the current price for Journey Medical (DERM)?

A

The stock price for Journey Medical (NASDAQ: DERM) is $5.23 last updated November 20, 2024 at 4:17 PM EST.

Q

Does Journey Medical (DERM) pay a dividend?

A

There are no upcoming dividends for Journey Medical.

Q

When is Journey Medical (NASDAQ:DERM) reporting earnings?

A

Journey Medical’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Q

Is Journey Medical (DERM) going to split?

A

There is no upcoming split for Journey Medical.

Q

What sector and industry does Journey Medical (DERM) operate in?

A

Journey Medical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch